Tom Hochuli
Tom Hochuli is CEO of Current Biologics, which is focused on providing cell and gene therapy manufacturing and development services to the biotechnology and pharmaceutical industries. The startup supports Cincinnati Children’s efforts to expand on its leadership in the development, testing and cGMP manufacturing of biological therapeutics for early phase clinical trials. Hochuli previously was CEO of Vibalogics Holdings, and he has over 30 years of leadership experience in the biologics, pharmaceutical, medical device, and consumer products industries. Hochuli earned a bachelor’s in electrical and computer engineering from Clarkson University and an MBA from Rutgers.
Catherine Pearce
Catherine Pearce is currently the COO and Co-founder of CinCor, Inc. and a former co-founder of CinRx. She has more than 20 years of experience in pharmaceutical clinical development, business development, and R&D at companies including Merck, Ethicon, Teva and Medpace. Catherine has also served on various biotech Boards and drug development panels. Catherine received her BS at Xavier in 1997 and MBA in 2004 and a doctorate of health sciences from Nova Southeastern University in 2017.
